← back to search

Wanding Zhou

Translational Therapeutics (United States) · US
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Epigenetics and DNA Methylation, Cancer Genomics and Diagnostics, RNA modifications and cancer, and Genomics and Chromatin Dynamics.
h-index
77
citations
67,139
works
248
NIH funding
primary concept
Biology
email

Recent publications

Classifying AD and PART: An Epigenetic Signature of Cognitive Resilience
Alzheimer s & Dementia 2025cited by 0position: middledoi
PRC2-AgeIndex as a universal biomarker of aging and rejuvenation
Nature Communications 2024cited by 56position: middledoi
BISCUIT: an efficient, standards-compliant tool suite for simultaneous genetic and epigenetic inference in bulk and single-cell studies
Nucleic Acids Research 2024cited by 44position: firstdoi
Inflammatory and tissue injury marker dynamics in pediatric acute respiratory distress syndrome
Journal of Clinical Investigation 2024cited by 21position: middledoi
Comparative epigenome analysis using Infinium DNA methylation BeadChips
Briefings in Bioinformatics 2023cited by 50position: lastdoi
A mammalian methylation array for profiling methylation levels at conserved sequences
Nature Communications 2022cited by 213position: middledoi
Host methylation predicts SARS-CoV-2 infection and clinical outcome
Communications Medicine 2021cited by 78position: middledoi
Comprehensive Analysis of Genetic Ancestry and Its Molecular Correlates in Cancer
Cancer Cell 2020cited by 324position: middledoi
The Immune Landscape of Cancer
Immunity 2019cited by 799position: middledoi
Before and After: Comparison of Legacy and Harmonized TCGA Genomic Data Commons’ Data
Cell Systems 2019cited by 199position: middledoi
The Immune Landscape of Cancer
Immunity 2018cited by 6,153position: middledoi
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Cell 2018cited by 3,331position: middledoi
The chromatin accessibility landscape of primary human cancers
Science 2018cited by 1,316position: middledoi
Integrated Molecular Characterization of Testicular Germ Cell Tumors
Cell Reports 2018cited by 456position: middledoi
DNA methylation loss in late-replicating domains is linked to mitotic cell division
Nature Genetics 2018cited by 450position: firstdoi
A Gene Depleted DNA Methylation Canyon Maintains Hematopoietic Stem Cell Self-Renewal and NPM1c+ Leukemia By Regulating the Gene Expression of HOXA Cluster
Blood 2018cited by 0position: lastdoi
The genomic landscape of tuberous sclerosis complex
Nature Communications 2017cited by 236position: middledoi
An integrated map of structural variation in 2,504 human genomes
Nature 2015cited by 2,646position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Hui Shen · Van Andel Institute3 papers (2017–2024)Steve Horvath · Banyan Biomarkers (United States)3 papers (2022–2024)Peter W. Laird · Van Andel Institute2 papers (2018–2024)Benjamin P. Berman · Henderson Community College2 papers (2018–2024)Daniel J. Weisenberger · University of California, Los Angeles2 papers (2017–2018)Matteo Pellegrini · University of California, Los Angeles1 papers (2022–2022)Vittorio Sebastiano · Stanford University1 papers (2024–2024)Sandra Cottingham · Helen DeVos Children's Hospital1 papers (2017–2017)Daniel J. Simpson · University Hospitals Bristol and Weston NHS Foundation Trust1 papers (2024–2024)Edwin J. C. G. van den Oord · Virginia Commonwealth University1 papers (2024–2024)Emily Maciejewski · University of California, Los Angeles1 papers (2022–2022)M Snyder · Cardiovascular Institute of the South1 papers (2024–2024)Garrett Keim · Drexel University1 papers (2024–2024)Kurt Farrell · Allen Institute for Brain Science1 papers (2025–2025)Kristin E. Dittenhafer‐Reed · Hope College1 papers (2017–2017)Erica L. Carpenter · Abramson Cancer Center1 papers (2024–2024)Andrew D. Cherniack · Harvard University1 papers (2017–2017)Nadir Yehya · Children's Hospital of Philadelphia1 papers (2024–2024)Marco Morselli · University of California, Los Angeles1 papers (2022–2022) · 1 papers (2024–2024)